Company profile

Kyla

Mental Health & Digital Therapeutics

Company profile

About Kyla

Kyla is a workplace health technology company that provides comprehensive COVID-19 safety and testing solutions for employers. The company offers a complete suite of services including on-site drive-up and walk-up testing with 24-48 hour results, daily symptom monitoring through a mobile app, vaccine tracking, outbreak prevention protocols, and telemedicine access to board-certified physicians. Kyla's platform includes a real-time dashboard that allows employers to monitor workforce health status, manage testing schedules, and track employee clearance for work. The company's trained nurses can set up drive-through testing capable of processing up to 3,000 employees per van per day, with mail-in testing options available for remote workers. Kyla also provides outbreak prevention services including emergency same-day testing when positive cases are identified, contact tracing, and CDC-guideline-based protocols that are OSHA certified and JSAS approved. The platform integrates legal consent forms, COVID education compliance, and various testing types including molecular tests for current infection, IgM for recent exposure, and IgG antibody testing. Medical care is provided by a team of board-certified physicians, nurse practitioners, and physician assistants who have treated over 350,000 patients through the company's urgent care clinics, earning over 3,700 Google reviews with an average rating of 4.6. Kyla serves employers ranging from small businesses to enterprise-level customers with 10,000+ employees across multiple geographic markets.

Company description Kyla official website

Primary marketMental Health & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Kyla?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • COVID-19

Who it serves

  • Employers
  • Enterprise customers with 50-10,000+ employees
  • Large national chains

Deployment & integration

Cloud Saas · Hybrid · On Premise deployment with recorded integration context.

Geographic context

MarketsFlorida · Georgia · Los Angeles Area · Nevada · Oakland Area · Pennsylvania · Sacramento Area · San Francisco Area · San Jose Area · Texas
Company sourceOfficial website

Company milestones

Platform expansion

Featured in news coverage in August-September 2020 regarding COVID-19 testing for schools and workplaces

Partnerships

Recorded partners

No partners are currently listed.

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Kyla App

Daily symptom monitoring and medical chat app for employees

Software · Cloud SaaSCompany source

Kyla COVID-Covered Platform

Complete COVID-19 workplace safety and testing management platform

Platform · Cloud SaaSCompany source

On-Site Testing Services

Drive-thru and walk-up COVID-19 testing at employer locations

Service · On PremiseCompany source

Outbreak Prevention Services

Emergency testing and contact tracing for COVID-19 workplace outbreaks

Service · HybridCompany source

Real Time Dashboard

Live workforce health status monitoring for employers

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

Research

Publications & preprints

Assessing Cardiovascular Disease Prevention Activities in the Denver, Colorado, Metropolitan Area: Building on an Existing Network to Enhance Emphasis on Equity.

American journal of public health · Jul 1, 2026

The hidden mysteries of our ice giant planets.

Nature communications · May 11, 2026

Health-related quality of life and economic burden associated with likely and diagnosed generalized anxiety disorder among the US general adult population.

Journal of affective disorders · May 1, 2026

Associations among Dietary Intakes, Blood Biomarkers, and Postmortem Brain Tissue Concentrations of Vitamins D and K in Older Adults.

The Journal of nutrition · Apr 1, 2026

Shared decision-making, the working alliance, and patient-centered care: A simultaneous concept analysis and review of the literature.

Patient education and counseling · Dec 1, 2025

Regular cannabis use modulates gamma functional connectivity with V1 during visual processing.

NeuroImage · Dec 1, 2025

Clinical validation

Clinical-trial records

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081 · Mentioned · RECRUITING

TReatment for ImmUne Mediated PathopHysiology

NCT04862221 · Mentioned · RECRUITING

AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion

NCT06029660 · Mentioned · RECRUITING

Study of Exposure to Chemicals in Consumer Products

NCT02471365 · Mentioned · COMPLETED

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

NCT06532890 · Mentioned · RECRUITING

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

NCT07164027 · Mentioned · RECRUITING

Regulatory

Regulatory records

No linked records are currently available.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

75% of testing employers found positive COVID-19 cases

Based on over 6,000 employee results

3000 employees tested per van per day

On-site drive-through testing capacity

24-48 hour test results

Standard turnaround time for on-site testing

Testing Employers (Aggregate)

Weekly COVID-19 testing and outbreak management for workforce safety

75% of testing employers found at least one positive COVID-19 case based on over 6,000 employee test results

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Vladimir Skorohod

MD

Antonio Aguilar

PA-C

Swetha Gurajala

PA

06 · Company updates

Updates from Kyla

Recent articles published on Kyla's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Mental Health & Digital Therapeutics

Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon